Stroke clot-buster trial
2,509 views · Published 23 May 2012 · 2:24 · Indexed 29 October 2026
Channel: The University of Edinburgh · 2012 · Education
Researchers find that stroke survivors are more able to look after themselves following treatment with rt-PA. Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment. The multi-centre, randomised study of more than 3000 patients is the world's largest ever trial of the drug rt-PA, which is given intravenously to patients who have suffered an acute ischemic stroke. The international trial - known as IST-3 - has found that for every 1000 patients given the clot-busting treatment within three hours of stroke, 80 more will survive and live without help from others than if they had not been given the drug. The findings of the study, led by the University, have been published in The Lancet alongside an analysis of all other trials of the drug that have been carried out in the past 20 years.
More from this channel
-
43:27
Meet the Crew of Space Shuttle Discovery
-
1:32:20
Soldier Meets Citizen: a public debate
-
0:51
Interview with Professor Peter Higgs
-
3:09
Edinburgh launches project to tackle pneumonia
-
0:48
Gene study offers clues for drug development
-
4:51
Links to Africa highlighted
-
1:12:26
Diana Eck - The New Cosmopolis: Cities and the Realities of Religious Pluralism
-
1:19:11
Diana Eck - Religious Views of Religious Pluralism II